Dario J. Englot

Perils and progress in epilepsy surgery utilization: Twenty‐five years later

Abstract More than 25 years have passed since the first randomized controlled trial (RCT) established that surgery is superior to continued anti‐seizure medication (ASM) for drug‐resistant temporal lobe epilepsy, and nearly as long since a joint practice parameter urged that appr...